<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC3065466/results/search/disease/results.xml">
  <result pre=": Research Article : Biology : Population Biology : Epidemiology:" exact="Infectious" post="Disease Epidemiology : Population Dynamics: Disease Dynamics: Population Modeling"/>
  <result pre="Research Article : Biology : Population Biology : Epidemiology: Infectious" exact="Disease" post="Epidemiology : Population Dynamics: Disease Dynamics: Population Modeling :"/>
  <result pre="Population Biology : Epidemiology: Infectious Disease Epidemiology : Population Dynamics:" exact="Disease" post="Dynamics: Population Modeling : Mathematics : Probability Theory: Stochastic"/>
  <result pre="Mathematics : Probability Theory: Stochastic Processes : Medicine : Epidemiology:" exact="Infectious" post="Disease Epidemiology : Infectious Diseases : Viral Diseases: Influenza:"/>
  <result pre=": Probability Theory: Stochastic Processes : Medicine : Epidemiology: Infectious" exact="Disease" post="Epidemiology : Infectious Diseases : Viral Diseases: Influenza: Infectious"/>
  <result pre="Stochastic Processes : Medicine : Epidemiology: Infectious Disease Epidemiology :" exact="Infectious" post="Diseases : Viral Diseases: Influenza: Infectious Disease Modeling: Public"/>
  <result pre="Processes : Medicine : Epidemiology: Infectious Disease Epidemiology : Infectious" exact="Diseases" post=": Viral Diseases: Influenza: Infectious Disease Modeling: Public Health"/>
  <result pre="Medicine : Epidemiology: Infectious Disease Epidemiology : Infectious Diseases :" exact="Viral" post="Diseases: Influenza: Infectious Disease Modeling: Public Health Can Antiviral"/>
  <result pre="Infectious Disease Epidemiology : Infectious Diseases : Viral Diseases: Influenza:" exact="Infectious" post="Disease Modeling: Public Health Can Antiviral Drugs Contain Pandemic"/>
  <result pre="Disease Epidemiology : Infectious Diseases : Viral Diseases: Influenza: Infectious" exact="Disease" post="Modeling: Public Health Can Antiviral Drugs Contain Pandemic Influenza"/>
  <result pre="past pandemics it is estimated that at least 80% of" exact="primary" post="household cases must present upon show of symptoms to"/>
  <result pre="containment of transmission is unlikely. page-count: Introduction The threat from" exact="avian influenza" post="H1N5 prompted many countries to establish a stockpile of"/>
  <result pre="prophylactic use of antiviral drugs is able to reduce the" exact="total" post="number individuals infected then there will be fewer cases"/>
  <result pre="individuals infected then there will be fewer cases with severe" exact="disease" post="in need of treatment with antiviral drugs. The optimal"/>
  <result pre="and protection from infection, as well as the transmission and" exact="disease" post="progression characteristics of the new virus strain. Many of"/>
  <result pre=", and denote the proportion of individuals who are susceptible," exact="infectious" post="and removed at time . The equations describing transmission"/>
  <result pre="be time-dependent. The initial reproduction number is the number of" exact="secondary" post="infections generated by a typical single primary case at"/>
  <result pre="time-dependent. The initial reproduction number is the number of secondary" exact="infections" post="generated by a typical single primary case at the"/>
  <result pre="the number of secondary infections generated by a typical single" exact="primary" post="case at the beginning when no one else has"/>
  <result pre="widespread transmission. For the moment suppose that each individual is" exact="symptomatic" post="and presents to the health service following onset of"/>
  <result pre="150 0.01 0.5 0.2 The recovery rate gives a mean" exact="infectious" post="period of four days, the vaccination rate means that"/>
  <result pre="pandemic influenza, seems sensible on the basis of past experience." exact="Attack" post="rates observed during the pandemics of 1918, 1957, 1968"/>
  <result pre="limit community distribution of antiviral drugs to cases with laboratory-confirmed" exact="infection" post="and individuals with confirmed exposure. Unfortunately, laboratory confirmation and"/>
  <result pre="the previous generation, where household generation 0 contains only the" exact="primary" post="household case. For our purpose we also include the"/>
  <result pre="effect on , the mean number of cases a generation-" exact="infective" post="generates outside their household. As in [25], individuals who"/>
  <result pre="within-household transmission with the modification that the probability of avoiding" exact="infection" post="is generation-dependent. The 2001 Australian census data was used"/>
  <result pre="doses are dispensed to household members two days after the" exact="primary" post="case is infected, and (iii) doses are dispensed four"/>
  <result pre="infected, and (iii) doses are dispensed four days after the" exact="primary" post="case is infected. In order to determine the largest"/>
  <result pre="antiviral drugs on the reproduction number when a fraction of" exact="primary" post="household cases fails to present early enough for the"/>
  <result pre="parameters assume their baseline value. This allows for one imported" exact="infective" post="per day for every million population members, for a"/>
  <result pre="the estimate of indicates containment is infeasible. More generally, the" exact="total" post="number of antiviral doses used, as given by (4),"/>
  <result pre="models under quite general assumptions about characteristics of transmission and" exact="disease" post="progression. The enormous benefit of local containment of a"/>
  <result pre="now transmission through a community of households. Suppose that every" exact="infection" post="that an individual generates outside their own household is"/>
  <result pre="During the containment phase of the pandemic, the force of" exact="infection" post="acting on a susceptible from outside the household is"/>
  <result pre="outside the household is negligible relative to the force of" exact="infection" post="exerted by an infectious household member. Using this we"/>
  <result pre="negligible relative to the force of infection exerted by an" exact="infectious" post="household member. Using this we can show that, in"/>
  <result pre="randomly from the community and is the mean number of" exact="primary" post="cases generated in the community by all the cases"/>
  <result pre="in terms of , the mean number of individuals an" exact="infective" post="infects outside their household, and , the probability that"/>
  <result pre="and , the probability that a susceptible household partner avoids" exact="infectious" post="contact with a household case during the latter's infectious"/>
  <result pre="avoids infectious contact with a household case during the latter's" exact="infectious" post="period. These interpretations of and apply for a totally"/>
  <result pre="(a) antivirals are dispensed at onset of symptoms in the" exact="primary" post="case (two days after infection), (b) antivirals are dispensed"/>
  <result pre="are dispensed two days after onset of symptoms in the" exact="primary" post="household case, [2], [4] and (c) no antiviral drugs"/>
  <result pre="family members two days after onset of symptoms in the" exact="primary" post="case expands the set of parameter values for which"/>
  <result pre="In contrast, dispensing drugs at onset of symptoms in the" exact="primary" post="case expands the set of parameter values for which"/>
  <result pre="if they are dispensed at onset of symptoms in the" exact="primary" post="case. Figure 4 Curves for which the reproduction number"/>
  <result pre="(a) antivirals are dispensed at onset of symptoms in the" exact="primary" post="household case, (b) antivirals are dispensed two days after"/>
  <result pre="antivirals are dispensed two days after symptom onset in the" exact="primary" post="case, and (c) no antiviral drugs are dispensed. For"/>
  <result pre="as reflected in the model, individuals infected with influenza become" exact="infectious" post="prior to onset of symptoms and the bulk of"/>
  <result pre="prior to onset of symptoms and the bulk of their" exact="total" post="infection potential has passed 2–3 days after symptom onset."/>
  <result pre="to onset of symptoms and the bulk of their total" exact="infection" post="potential has passed 2–3 days after symptom onset. Failure"/>
  <result pre="total infection potential has passed 2–3 days after symptom onset." exact="Failure" post="to present Figure 4 illustrates that failure to present"/>
  <result pre="to have a way of determining how the fraction of" exact="primary" post="household cases who do not present, or present late,"/>
  <result pre="the chance of containing transmission. Let denote the proportion of" exact="primary" post="household cases that fail to present early. Under the"/>
  <result pre="Under the assumption that every member of a household whose" exact="primary" post="case presents early receives a dose of antiviral drugs"/>
  <result pre="it is not possible to contain transmission if the proportion" exact="primary" post="household cases who fail to present early is greater"/>
  <result pre="drugs are dispensed to members of those households where the" exact="primary" post="case presents early. For values of below the curve"/>
  <result pre="Then containment of transmission requires that less than 29% of" exact="primary" post="cases fail to present early when , and less"/>
  <result pre="values of below the curve, where is the proportion of" exact="primary" post="household cases who fail to present early, is the"/>
  <result pre="that receive antiviral drugs at onset of symptoms in the" exact="primary" post="household case in households of size 2, 3 and"/>
  <result pre="late (two days after the onset of symptoms in the" exact="primary" post="case) in households of size 2, 3 and 4,"/>
  <result pre="avoids being infected by a given household infective, in the" exact="absence of" post="antiviral drugs. Figure 6 Power of a test to"/>
  <result pre="infectivity and their effect on susceptibility is to induce full," exact="partial" post="and zero protection, respectively. Simulations for curve (d) assume"/>
  <result pre="for curve (d) assume no effect on infectivity and a" exact="partial" post="effect on susceptibility. The antiviral effect on susceptibility is"/>
  <result pre="susceptibility is to reduce the probability of transmission of an" exact="infection" post="occurring during a contact by a factor for a"/>
  <result pre="The effect on infectivity depends on the time when the" exact="infective" post="starts taking the antiviral drug and is measured by"/>
  <result pre="effect scenario with , no effect on infectivity, and ," exact="partial" post="effect on susceptibility. When considering the results in Figure"/>
  <result pre="would be very challenging. We would therefore like , the" exact="total" post="number of household outbreaks monitored, to be less than"/>
  <result pre="by including a moderate effect on susceptibility, illustrates that a" exact="total" post="of household outbreaks are needed to detect an effect"/>
  <result pre="containment of transmission, if possible, requires early presentation by the" exact="primary" post="household case. We cannot wait for laboratory confirmation of"/>
  <result pre="infection. Next we allowed for failure by a fraction of" exact="primary" post="household cases to present soon after onset of symptoms."/>
  <result pre="is not possible if more than a modest fraction of" exact="primary" post="household cases fail to present early. In our illustration"/>
  <result pre="present early. In our illustration we required the proportion of" exact="primary" post="cases who fail to present early to be smaller"/>
  <result pre="cases, mildly-symptomatic cases who do not bother to present and" exact="symptomatic" post="cases unable to gain timely access to a health"/>
  <result pre="holds under a very wide range of community settings and" exact="disease" post="characteristics. The likelihood of achieving depends critically on the"/>
  <result pre="depends critically on the transmission characteristics of the newly emerged" exact="disease" post="and our ability to deliver antiviral drugs early enough"/>
  <result pre="as in some other localities, most early cases were imported" exact="infections" post="indicating that was maintained for a substantial period, [31]."/>
  <result pre="Med3378748809302301 11NicholsonKGAokiFYOsterhausATrottierSCarewiczOet al.2000Efficacy and safety of oseltamivir in treatment of" exact="acute" post="influenza: a randomised controlled trial.Lancet3551845185010866439 12TreanorJJet al.2000Efficacy and safety"/>
  <result pre="and safety of the oral neuraminidase inhibitor oseltamivir in treating" exact="acute" post="influenza.J Am Med Assoc28310161024 13JeffersonTDemicheliVRivettiDJonesMPietrantonjCDet al.2006Antivirals for influenza in"/>
  <result pre="estimation.Epidemiology2184284620805752 20MercerGNGlassKBeckerNG2010Effective reproduction numbers are commonly overestimated early in a" exact="disease" post="outbreak.Statist Medin press 21CaleyPPhilpDJMcCrackenK2008Quantifying social distancing arising from pandemic"/>
  <result pre="of the household distribution on transmission and control of highly" exact="infectious" post="diseases.Math Biosci1272072197795319 24BallFLyneO2006Optimal vaccination schemes for epidemics among a"/>
  <result pre="for epidemics among a population of households, with application to" exact="variola minor" post="in Brazil.Statist Meth Med Research15481497 25GlassKBeckerNG2009Estimating antiviral effectiveness against"/>
  <result pre="using household data.J Roy Soc Interface669570319064345 26BaileyNTJ1975The mathematical theory of" exact="infectious diseases" post="and its applications.London, UKGriffin 27BeckerNG1989Analysis of Infectious Disease Data.London,"/>
  <result pre="theory of infectious diseases and its applications.London, UKGriffin 27BeckerNG1989Analysis of" exact="Infectious" post="Disease Data.London, UKChapman and Hall 28AlexanderRAGovernDM1994A new and simpler"/>
  <result pre="of infectious diseases and its applications.London, UKGriffin 27BeckerNG1989Analysis of Infectious" exact="Disease" post="Data.London, UKChapman and Hall 28AlexanderRAGovernDM1994A new and simpler approximation"/>
  <result pre="data needed for an early estimate of transmissibility when an" exact="infectious disease" post="emerges.Euro Surveill15pii = 19603 31MercerGNGlassKBeckerNG2011Effective reproduction numbers are commonly overestimated early"/>
  <result pre="needed for an early estimate of transmissibility when an infectious" exact="disease" post="emerges.Euro Surveill15pii = 19603 31MercerGNGlassKBeckerNG2011Effective reproduction numbers are commonly overestimated early"/>
  <result pre="Surveill15pii = 19603 31MercerGNGlassKBeckerNG2011Effective reproduction numbers are commonly overestimated early in a" exact="disease" post="outbreak.Statist Medin press, DOI: 10.1002/sim.4174"/>
 </snippets>
</snippetsTree>
